Tuesday, September 16, 2025
HomeNews

News

Innovative Drug Delivery Company Partners with Fortune 100 Global Foundry for Next-Generation Artificial Pancreas

AiTA Bio, a New York-based bio-MEMS company, today announced it has secured $8.5 million in Series A funding led by Hammerstone Capital, BlackPoint Partners,...

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule...

Strata Oncology Enrolls First Patient in Strata PATH Trial Investigating New Pan-Tumor Indications for Approved Cancer Therapies

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, announced enrollment of the first patient in the Strata Precision...

Memora Health and Reimagine Care Partner to Support Home-Centered Cancer Care for Patients and Care Teams

Memora Health, the leading technology platform for virtual care delivery and complex care management, announced a partnership with Reimagine Care, an innovative provider of...

Evo Foods and Ginkgo Bioworks Announce Partnership to Develop Animal-Free Egg Products

Evo Foods, a consumer packaged goods company creating the next generation of plant-based substitutes for animal products, and Ginkgo Bioworks, the leading horizontal platform...
0FansLike
0FollowersFollow
spot_img

Hot Topics